Metastatic Breast Cancer
Clinical Trial - LA
Have you taken Ibrance® or Kisqali®? The Amelia 1 clinical trial is OPEN in multiple LA locations. Please contact the study manager via phone or
email below.
Ask about Study SDX-0103
Hoag Memorial Hospital Presbyterian
**Open to Recruitment
One Hoag Drive
Newport Beach, CA 92663
Contact: Jericho Rabago, BSN, RN
(949) 764-6796
Principal Investigator: Dr. Chaitali Nangia
Loma Linda University Cancer Center
**Open to Recruitment
11234 Anderson St.
Loma Linda, CA 92354
Contact: Lorena Garcia, CRC
(909) 651-5612
Principal Investigator: Gayathri Nagaraj, MD
Has Your Breast Cancer Spread Despite CDK 4/6 Treatment?
The Amelia 1 breast cancer clinical trial is testing patients with the PIK3CA gene mutation. Post-menopausal women with advanced or metastatic breast cancer who live in the greater Los Angeles area are invited to apply to join the trial. Contact the clinical trial site closest to you for more details.
Amelia 1 is a clinical study developed by SynDevRx, Inc.
SynDevRX, Inc. Copyright 2022
Terms of Use
|
Privacy Policy
View our Clinical Trial Site Pages below for more details
